captopril has been researched along with Hyperlipidemias in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Jaiswal, A; Semwal, BC; Singh, S | 1 |
| Feng, M; He, ZM; Lei, YP; Lin, Y; Lu, CW; Xiong, Y | 1 |
| Fisher, ND; Freeman, KD; Hollenberg, NK; Lansang, CM; Stevanovic, RD | 1 |
| Antelava, NA; Gogolauri, MI; Gongadze, NV; Kezeli, TD; Pachkoriia, KZ | 1 |
| Aberg, G; Beyer, S; Kowala, MC; Recce, R | 1 |
| Aberg, G; Grove, RI; Kowala, MC | 1 |
| Darioli, R; Greminger, P; Riesen, W; Simeon-Dubach, D; Waeber, B; Wunderlin, R | 1 |
| Beucler, I; Dairou, F; Février, B; Scemama, M | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Dusleag, J; Klein, W; Ratheiser, K; Seitl, K; Titscher, G | 1 |
| Chobanian, AV | 1 |
1 review(s) available for captopril and Hyperlipidemias
| Article | Year |
|---|---|
ACE-inhibitors and atherosclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Arteriosclerosis; Captopril; Cilazapril; Disease Models, Animal; Haplorhini; Hyperlipidemias; Lipid Metabolism; Peptidyl-Dipeptidase A; Pyridazines; Rabbits; Rats | 1992 |
3 trial(s) available for captopril and Hyperlipidemias
| Article | Year |
|---|---|
Combined treatment with captopril, hydrochlorothiazide and pravastatin in dyslipidemic hypertensive patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Captopril; Combined Modality Therapy; Diuretics; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Male; Middle Aged; Pravastatin; Prospective Studies; Sodium Chloride Symporter Inhibitors | 1995 |
[Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
Topics: Antihypertensive Agents; Captopril; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Lipids; Male; Middle Aged; Oxazoles; Rilmenidine; Time Factors | 1996 |
A "lipo-protective" effect of a fixed combination of captopril and hydrochlorothiazide in antihypertensive therapy.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Cholesterol; Drug Combinations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Lipid Metabolism; Lipoproteins, HDL; Male; Middle Aged; Prospective Studies; Quality of Life | 1992 |
7 other study(ies) available for captopril and Hyperlipidemias
| Article | Year |
|---|---|
Effect of Captopril and BQ123 Endothelin-1 Antagonist on Experimentally Induced Hyperlipidemic Nephropathy in Rats.
Topics: Animals; Captopril; Endothelin-1; Hyperlipidemias; Kidney Diseases; Rats | 2023 |
Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits.
Topics: Amidohydrolases; Animals; Arginine; Captopril; Diet, High-Fat; Endothelium, Vascular; Enzyme Inhibitors; Hyperlipidemias; Male; Rabbits | 2017 |
Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.
Topics: Antihypertensive Agents; Blood Glucose; Captopril; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Gastroparesis; Homeostasis; Humans; Hyperlipidemias; Hypertension; Renin; Sodium, Dietary; Thyroid Diseases | 2007 |
[Comparative characteristic of angiotensin-converting enzyme inhibitor--captopril and the angiotensin II receptor blokers--losartan action on the oxidative metabolism in experimental hyperlipidemia in rabbits].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Catalase; Disease Models, Animal; Hyperlipidemias; Lipids; Losartan; Nitric Oxide; Oxidative Stress; Rabbits; Superoxide Dismutase; Treatment Outcome | 2007 |
Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril.
Topics: Analysis of Variance; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Captopril; Cell Count; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cricetinae; Diet, Atherogenic; Disease Models, Animal; Foam Cells; Fosinopril; Heart Rate; Hyperlipidemias; Image Processing, Computer-Assisted; Macrophages; Male | 1995 |
Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids.
Topics: Animals; Aorta; Arteriosclerosis; Blood Pressure; Captopril; Cholesterol; Cricetinae; Foam Cells; Fosinopril; Heart Rate; Hyperlipidemias; Lipids; Macrophages; Male | 1994 |
The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Captopril; Heart Diseases; Hyperlipidemias; Hypertension; Propranolol; Rabbits; Risk Factors | 1990 |